Results 211 to 220 of about 106,311 (253)
Some of the next articles are maybe not open access.
Low‐molecular‐weight heparins and angiogenesis
APMIS, 2006The involvement of the vascular system in malignancy encompasses not only angiogenesis, but also systemic hypercoagulability and a pro‐thrombotic state, and there is increasing evidence that pathways of blood coagulation and angiogenesis are reciprocally linked.
openaire +2 more sources
Low molecular weight heparin and atherosclerosis
Current Atherosclerosis Reports, 2004Low molecular weight heparin (LMWH) has dramatically impacted the treatment of venous thromboembolic disease and acute coronary syndromes. Recent studies help define the role of these agents for patients undergoing percutaneous coronary interventions and for patients treated with thrombolytic agents for ST-segment elevation myocardial infarction ...
openaire +2 more sources
Heparin and Low-Molecular-Weight Heparin
Chest, 2004Jack Hirsh, Robert Raschke
openaire +2 more sources
Preparation of low-molecular-weight sodium alginate by ozonation
Carbohydrate Polymers, 2021Wu Yue
exaly
Sustained weight loss may reduce cancer risk
Ca-A Cancer Journal for Clinicians, 2022Mike Fillon
exaly